# The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB

> **NCT03830671** · PHASE4 · COMPLETED · sponsor: **Beijing Chest Hospital** · enrollment: 515 (actual)

## Conditions studied

- Multi-drug Resistant Tuberculosis

## Interventions

- **DRUG:** 18-month regimen containing 6 anti-TB drugs

## Key facts

- **NCT ID:** NCT03830671
- **Lead sponsor:** Beijing Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-08
- **Primary completion:** 2022-06-08
- **Final completion:** 2022-06-08
- **Target enrollment:** 515 (ACTUAL)
- **Last updated:** 2022-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03830671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03830671, "The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03830671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*